Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Handbook of Community Psychology by

bigCover of the book Current Issues in Clinical Psychology by

bigCover of the book Neural Metabolism In Vivo by

bigCover of the book Globalization, Growth and Sustainability by

bigCover of the book Learning, Innovation and Urban Evolution by

bigCover of the book The Ontogeny of Human Bonding Systems by

bigCover of the book Dictionary of Ceramic Science and Engineering by

bigCover of the book Unified low-power design flow for data-dominated multi-media and telecom applications by

bigCover of the book Traffic and QoS Management in Wireless Multimedia Networks by

bigCover of the book Haemophilus, Actinobacillus, and Pasteurella by

bigCover of the book Intelligent knowledge based systems in electrical power engineering by

bigCover of the book Successful Prevention and Youth Development Programs by

bigCover of the book Frozen Section Library: Gynecologic Pathology Intraoperative Consultation by

bigCover of the book Prevention of Kidney Disease and Long-Term Survival by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy